Modeling early Epstein-Barr virus infection in Drosophila melanogaster:: The BZLF1 protein

被引:20
|
作者
Adamson, AL [1 ]
Wright, N [1 ]
LaJeunesse, DR [1 ]
机构
[1] Univ N Carolina, Dept Biol, Greensboro, NC 27402 USA
关键词
D O I
10.1534/genetics.105.042572
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis and is associated with several forms of cancer, including lymphomas and nasopharyngeal carcinoma. The EBV immediate-early protein BZLF1 functions as a transcriptional activator of EBV early gene expression and is essential for the viral transition between latent and lytic replication. In addition to its role in the EBV life cycle, BZLF1 (Z) also has profound effects upon the host cellular environment, including disruption of cell cycle regulation, signal transduction pathways, and transcription. In an effort to understand the nature of Z interactions with the host cellular environment, we have developed a Drosophila model of early EBV infection, where we have expressed Z in the Drosophila eye. Using this system, we have identified a highly conserved interaction between the Epstein-Barr virus Z protein and shaven, a Drosophila homolog of the human Pax2/5/8 family of genes. Pax5 is a well-characterized human gene involved with B-cell development. The B-cell-specific Pax5 also promotes the transcription of EBV latent genes from the EBV Wp promoter. Our work clearly demonstrates that the Drosophila system is an appropriate and powerful tool for identifying the underlying genetic networks involved in human infections disease.
引用
收藏
页码:1125 / 1135
页数:11
相关论文
共 50 条
  • [41] ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus
    Kraus, RJ
    Perrigoue, JG
    Mertz, JE
    JOURNAL OF VIROLOGY, 2003, 77 (01) : 199 - 207
  • [42] Shutoff of BZLF1 Gene Expression Is Necessary for Immortalization of Primary B Cells by Epstein-Barr Virus
    Yu, Xianming
    McCarthy, Patrick J.
    Wang, Zhenxun
    Gorlen, Daniel A.
    Mertz, Janet E.
    JOURNAL OF VIROLOGY, 2012, 86 (15) : 8086 - 8096
  • [43] Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus
    Gutiérrez, MI
    Ibrahim, MM
    Dale, JK
    Greiner, TC
    Straus, SE
    Bhatia, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (23) : 1757 - 1763
  • [44] Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler
    Patel, S
    Zuckerman, M
    Smith, M
    JOURNAL OF VIROLOGICAL METHODS, 2003, 109 (02) : 227 - 233
  • [45] Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection
    Elliott, SL
    Pye, SJ
    Schmidt, C
    Cross, SM
    Silins, SL
    Misko, IS
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04): : 1068 - 1072
  • [46] BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
    Woellmer, Anne
    Arteaga-Salas, Jose M.
    Hammerschmidt, Wolfgang
    PLOS PATHOGENS, 2012, 8 (09)
  • [47] Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma
    Tomokazu Yoshizaki
    Hiroko Miwa
    Hajime Takeshita
    Hiroshi Sato
    Mitsuru Furukawa
    Journal of Cancer Research and Clinical Oncology, 2000, 126 (2) : 69 - 73
  • [48] EPSTEIN-BARR-VIRUS BZLF1 TRANSACTIVATOR IS A NEGATIVE REGULATOR OF JUN
    SATO, H
    TAKESHITA, H
    FURUKAWA, M
    SEIKI, M
    JOURNAL OF VIROLOGY, 1992, 66 (08) : 4732 - 4736
  • [49] Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma
    Yoshizaki, T
    Miwa, H
    Takeshita, H
    Sato, H
    Furukawa, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (02) : 69 - 73
  • [50] Matrix metalloproteinase 9 is induced by the Epstein–Barr virus BZLF1 transactivator
    Tomokazu Yoshizaki
    Hiroshi Sato
    Shigeyuki Murono
    Joseph S. Pagano
    Mitsuru Furukawa
    Clinical & Experimental Metastasis, 1999, 17 : 431 - 436